Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol[ISRCTN33042138]

BACKGROUND: We have recently reported successful treatment of patients with chronic pain syndromes using human pooled intravenous immunoglobulin (IVIG) in a prospective, open-label cohort study. A randomised, placebo controlled, double blinded study is needed to confirm these results. We chose to st...

Descripción completa

Detalles Bibliográficos
Autores principales: Goebel, Andreas, Moore, Andrew, Weatherall, Rosamund, Roewer, Norbert, Schedel, Robert, Sprotte, Guenter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149450/
https://www.ncbi.nlm.nih.gov/pubmed/12590652
http://dx.doi.org/10.1186/1471-2377-3-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149450/
https://www.ncbi.nlm.nih.gov/pubmed/12590652
http://dx.doi.org/10.1186/1471-2377-3-1

Ejemplares similares